News

Liberum appointed Joint Corporate Broker to MedicX Fund Limited

10 May 2018 | Joint Corporate Broker

Liberum is pleased to announce its appointment as Joint Corporate Broker to MedicX Fund Limited.

MedicX is a specialist primary healthcare REIT which invests in modern, purpose-built primary healthcare properties in the UK & Republic of Ireland. The Company has a portfolio of 151 completed properties with an average value of £4.4m.

MedicX selectively buys high quality dominant assets or forward-funds new schemes under framework agreements with a range of experienced developers in both the UK and the Republic of Ireland.

The fund is listed on the Premium Segment of the Main Market and has a market capitalisation of c.£346m.

Liberum has been appointed as Joint Corporate Broker alongside Canaccord, with immediate effect.

Liberum Capital Limited is authorised and regulated by the Financial Conduct Authority / Registered in England & Wales No. 5912554 / Liberum Capital Inc. is a FINRA Member Firm and is regulated by the Securities and Exchange Commission (SEC)